Crossmark Global Holdings, Inc. Gsk PLC Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$42.05 - $47.77 $30,275 - $34,394	-720 Reduced 2.37%	29,680 $1.29 Million
Q1 2022 May 11, 2022	BUY	$40.23 - $47.74 $105,402 - $125,078	2,620 Added 9.43%	30,400 $1.32 Million
Q4 2021 Jan 10, 2022	SELL	$38.88 - $45.31 $388 - $453	-10 Reduced 0.04%	27,780 $1.23 Million
Q3 2021 Oct 21, 2021	BUY	$38.79 - $43.16 $386,348 - $429,873	9,960 Added 55.86%	27,790 $1.06 Million
Q3 2021 Oct 13, 2021	SELL	$38.79 - $43.16 $375,099 - $417,357	-9,670 Reduced 35.16%	17,830 $824,000
Q2 2021 Jul 21, 2021	SELL	$36.52 - $41.46 $46,745 - $53,068	-1,280 Reduced 4.45%	27,500 $1.1 Million
Q1 2021 Apr 15, 2021	SELL	$34.27 - $40.01 $402,124 - $469,477	-11,734 Reduced 28.96%	28,780 $1.03 Million
Q4 2020 Jan 14, 2021	BUY	$34.07 - $39.94 $17,920 - $21,008	526 Added 1.32%	40,514 $1.49 Million
Q3 2020 Oct 08, 2020	BUY	$38.11 - $42.99 $45,732 - $51,588	1,200 Added 3.09%	39,988 $1.51 Million
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $31,659 - $36,432	-836 Reduced 2.11%	38,788 $1.58 Million
Q1 2020 Apr 28, 2020	BUY	$32.47 - $48.83 $70,784 - $106,449	2,180 Added 5.82%	39,624 $1.53 Million
Q4 2019 Feb 06, 2020	BUY	$42.0 - $48.25 $120,120 - $137,995	2,860 Added 8.27%	37,444 $1.76 Million
Q3 2019 Oct 09, 2019	SELL	$40.46 - $43.52 $1.11 Million - $1.2 Million	-27,530 Reduced 44.32%	34,584 $1.48 Million
Q2 2019 Jul 09, 2019	BUY	$39.4 - $42.7 $50,826 - $55,083	1,290 Added 2.12%	62,114 $2.49 Million
Q1 2019 May 02, 2019	BUY	$38.57 - $42.69 $6,171 - $6,830	160 Added 0.26%	60,824 $2.54 Million
Q4 2018 Jan 31, 2019	SELL	$37.8 - $42.69 $17,388 - $19,637	-460 Reduced 0.75%	60,664 $2.32 Million
Q3 2018 Nov 08, 2018	BUY	$39.75 - $42.69 $973,080 - $1.05 Million	24,480 Added 66.8%	61,124 $2.46 Million
Q2 2018 Jul 31, 2018	SELL	$39.61 - $42.76 $2.38 Million - $2.57 Million	-60,050 Reduced 62.1%	36,644 $1.48 Million
Q1 2018 Apr 16, 2018	SELL	$36.18 - $40.15 $936,483 - $1.04 Million	-25,884 Reduced 21.12%	96,694 $3.78 Million
Q4 2017 Feb 05, 2018	SELL	$35.34 - $41.9 $16,963 - $20,112	-480 Reduced 0.39%	122,578 $4.35 Million
Q3 2016 Oct 25, 2017	BUY	N/A	123,058	123,058 $5 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account